The University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences (DOVS) has formally been announced as a partner site for Nightstar Therapeutics’ STAR Phase 3 Registrational Trial for NSR-REP1 in Choroideremia. This is the first …
The University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences (DOVS) has formally been announced as a partner site for Nightstar Therapeutics’ STAR Phase 3 Registrational Trial for NSR-REP1 in Choroideremia. This is the first …